EGFR and nasopharyngeal carcinoma: One patient with NPC who received induction chemotherapy combined with an immune checkpoint inhibitor combined with concurrent chemoradiotherapy for local residual disease and UFT later developed lung metastasis with high EGFR expression (Figure 7E).